Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Jared W. Young, Mark A. Geyer
Biochemical Pharmacology (2013) Vol. 86, Iss. 8, pp. 1122-1132
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Schizophrenia
Michael J. Owen, Akira Sawa, Preben Bo Mortensen
The Lancet (2016) Vol. 388, Iss. 10039, pp. 86-97
Open Access | Times Cited: 1560
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Kelly T. Dineley, Anshul A. Pandya, Jerrel L. Yakel
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 2, pp. 96-108
Open Access | Times Cited: 418
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Justin Davis, Harris A. Eyre, Felice N. Jacka, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 185-194
Open Access | Times Cited: 322
Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
Pascal Steullet, J-H Cabungcal, Joseph T. Coyle, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 7, pp. 936-943
Open Access | Times Cited: 313
Neuromodulation by acetylcholine: examples from schizophrenia and depression
Michael J. Higley, Marina R. Picciotto
Current Opinion in Neurobiology (2014) Vol. 29, pp. 88-95
Open Access | Times Cited: 163
The role of the habenula in drug addiction
Kenia M. Velasquez, David L. Molfese, Ramiro Salas
Frontiers in Human Neuroscience (2014) Vol. 8
Open Access | Times Cited: 144
Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity
Bernard Bloem, Rogier B. Poorthuis, Huibert D. Mansvelder
Frontiers in Neural Circuits (2014) Vol. 8
Open Access | Times Cited: 135
Therapeutic Potential ofα7 Nicotinic Acetylcholine Receptors
Daniel Bertrand, Chih-Hung L. Lee, Dorothy G. Flood, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 4, pp. 1025-1073
Open Access | Times Cited: 130
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
J.W. Young, MA Geyer
Journal of Psychopharmacology (2014) Vol. 29, Iss. 2, pp. 178-196
Open Access | Times Cited: 103
Classics in Chemical Neuroscience: Aripiprazole
Austen B. Casey, Clinton E. Canal
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1135-1146
Open Access | Times Cited: 98
Negative affective states and cognitive impairments in nicotine dependence
F. Scott Hall, Andre Der‐Avakian, Thomas J. Gould, et al.
Neuroscience & Biobehavioral Reviews (2015) Vol. 58, pp. 168-185
Open Access | Times Cited: 92
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives
Vinay Parikh, Munir Gunes Kutlu, Thomas J. Gould
Schizophrenia Research (2016) Vol. 171, Iss. 1-3, pp. 1-15
Open Access | Times Cited: 86
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 72
Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease
Valentina Echeverrı́a, Alex Yarkov, Gjumrakch Aliev
Progress in Neurobiology (2016) Vol. 144, pp. 142-157
Closed Access | Times Cited: 82
Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
William James Deardorff, Ahmad Shobassy, George T. Grossberg
Expert Review of Neurotherapeutics (2014) Vol. 15, Iss. 1, pp. 7-17
Closed Access | Times Cited: 75
Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor
Haitao Wu, M Okuyama, Yasushi Kajii, et al.
Schizophrenia Bulletin (2014) Vol. 40, Iss. Suppl 2, pp. S152-S158
Open Access | Times Cited: 71
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases
Lydia J. Bye, Rocio K. Finol‐Urdaneta, Han‐Shen Tae, et al.
The International Journal of Biochemistry & Cell Biology (2023) Vol. 157, pp. 106387-106387
Closed Access | Times Cited: 17
Astrocytic Regulation of Glutamate Transmission in Schizophrenia
Yu-Ying Mei, Dong Wu, Ning Zhou
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 56
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 656-667
Open Access | Times Cited: 53
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats
Agnieszka Nikiforuk, Tomasz Kos, Małgorzata Hołuj, et al.
Neuropharmacology (2015) Vol. 101, pp. 389-400
Closed Access | Times Cited: 51
Smokin‘ hot: adolescent smoking and the risk of psychosis
Antti Mustonen, T. Ahokas, Tanja Nordström, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 1, pp. 5-14
Open Access | Times Cited: 49
The role of nicotinic cholinergic neurotransmission in delusional thinking
Michael Caton, Enrique L. M. Ochoa, Francisco J. Barrantes
Schizophrenia (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 40
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker
Michael Noback, Savita G. Bhakta, Jo Talledo, et al.
Cognitive Affective & Behavioral Neuroscience (2024) Vol. 24, Iss. 2, pp. 269-278
Closed Access | Times Cited: 5
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker
Kenji Hashimoto
Current Pharmaceutical Design (2015) Vol. 21, Iss. 26, pp. 3797-3806
Open Access | Times Cited: 49
Targeting Brain α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Rationale and Current Status
Ana Sofía Vallés, Virginia Borroni, Francisco J. Barrantes
CNS Drugs (2014) Vol. 28, Iss. 11, pp. 975-987
Closed Access | Times Cited: 48
Page 1 - Next Page

Scroll to top